e-learning
resources
Virtual 2021
05.09.2021
Mechanistic pathways in chronic and new lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients
K. Paschalaki (London, United Kingdom), C. Rossios (London, United Kingdom), V. Gorgoulis (Athens, Greece), A. Randi (London, United Kingdom), P. Barnes (London, United Kingdom)
Source:
Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Session:
Mechanistic pathways in chronic and new lung diseases
Session type:
Oral Presentation
Number:
1214
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Paschalaki (London, United Kingdom), C. Rossios (London, United Kingdom), V. Gorgoulis (Athens, Greece), A. Randi (London, United Kingdom), P. Barnes (London, United Kingdom). Inhaled corticosteroids reduce senescence in endothelial progenitor cells from COPD patients. 1214
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pathophysiology of central apnoea: how do we distinguish normal from abnormal?
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Endoscopy
Related content which might interest you:
Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis
Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019
Year: 2019
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Inhaled corticosteroids and the growth of lung function in children
Source: Eur Respir J 2004; 23: 795-796
Year: 2004
Inhaled corticosteroids decrease exercise-induced inflammation in patients with COPD
Source: Annual Congress 2007 - Mechanisms of exercise intolerance in cardiorespiratory disease
Year: 2007
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Source: Eur Respir J 2006; 27: 529-541
Year: 2006
Inhaled iloprost suppresses the cardinal features of asthma
via
inhibition of airway dendritic cell function
Source: Eur Respir J 2007; 30: Suppl. 51, 495s
Year: 2007
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
Decreased number of circulating endothelial progenitor cells in patients with emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Corticosteroids and beta2-agonists modify hyaluronic acid homeostasis in human airway smooth muscle cells in asthma and COPD
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Inhaled corticosteroids (ICS) attenuates epithelial mesenchymal transition (EMT) in COPD: A key to understanding long term benefits?
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Features of endothelial dysfunction at the patients with bronchial asthma treated by oral glucocorticoids
Source: Eur Respir J 2002; 20: Suppl. 38, 480s
Year: 2002
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation
Source: Eur Respir J, 54 (3) 1901088; 10.1183/13993003.01088-2019
Year: 2019
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Corticosteroids and beta2-agonists regulate pathologic homeostasis of hyaluronic acid in human airway smooth muscle cells from patients with asthma and COPD. Therapeutic relevance
Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs
Year: 2010
Endothelial progenitor cells are dysfunctional in smokers and COPD patients due to increased DNA damage and senescence
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Effect of targeted therapy on circulating endothelial progenitor cells in precapillary pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept